Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Epidemiology
Published in: European Journal of Epidemiology 8/2011

Open Access 01-08-2011

The Rotterdam Study: 2012 objectives and design update

Authors: Albert Hofman, Cornelia M. van Duijn, Oscar H. Franco, M. Arfan Ikram, Harry L. A. Janssen, Caroline C. W. Klaver, Ernst J. Kuipers, Tamar E. C. Nijsten, Bruno H. Ch. Stricker, Henning Tiemeier, André G. Uitterlinden, Meike W. Vernooij, Jacqueline C. M. Witteman

Published in: European Journal of Epidemiology | Issue 8/2011

Login to get access

Abstract

The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, oncological, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over a 1,000 research articles and reports (see www.​erasmus-epidemiology.​nl/​rotterdamstudy). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.
Literature
1.
Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029–31.PubMedCrossRef
2.
Peto R, Doll R. There is no such thing as aging. BMJ. 1997;315(7115):1030–2.PubMed
3.
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403–22.PubMedCrossRef
4.
Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819–29.PubMedCrossRef
5.
Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin GP, Kuipers EJ, et al. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol. 2009;24(9):553–72.PubMedCrossRef
6.
Hepworth SJ, Law GR, Lawlor DA, McKinney PA. Early life patterns of common infection: a latent class analysis. Eur J Epidemiol. 2010;25(12):875–83.PubMedCrossRef
7.
Gao X, Hofman A, Hu Y, Lin HD, Zhu CW, Jeekel J, et al. The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol. 2010;25(12):885–93.PubMedCrossRef
8.
Jaddoe VWV, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA, Steegers EAP, et al. The Generation R Study: design and cohort update 2010. Eur J Epidemiol. 2010;25(11):823–41.PubMedCrossRef
9.
10.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.PubMedCrossRef
11.
Harteloh P, de Bruin K, Kardaun J. The reliability of cause-of-death coding in The Netherlands. Eur J Epidemiol. 2010;25(8):531–8.PubMedCrossRef
12.
Pomp ER, Van Stralen KJ, Le Cessie S, Vandenbroucke JP, Rosendaal FR, Doggen CJM. Experience with multiple control groups in a large population-based case-control study on genetic and environmental risk factors. Eur J Epidemiol. 2010;25(7):459–66.PubMedCrossRef
13.
Schmidt-Pokrzywniak A, Stang A. Study of return rate and return time of undeliverable postal letters. Eur J Epidemiol. 2010;25(7):467–70.PubMedCrossRef
14.
Touvier M, Mejean C, Kesse-Guyot E, Pollet C, Malon A, Castetbon K, et al. Comparison between web-based and paper versions of a self-administered anthropometric questionnaire. Eur J Epidemiol. 2010;25(5):287–96.PubMedCrossRef
15.
Huybrechts KF, Mikkelsen EM, Christensen T, Riis AH, Hatch EE, Wise LA, et al. A successful implementation of e-epidemiology: the Danish pregnancy planning study ‘Snart-Gravid’. Eur J Epidemiol. 2010;25(5):297–304.PubMedCrossRef
16.
Jacobsen TN, Nohr EA, Frydenberg M. Selection by socioeconomic factors into the Danish National Birth Cohort. Eur J Epidemiol. 2010;25(5):349–55.PubMedCrossRef
17.
Wenemark M, Vernby A, Norberg AL. Can incentives undermine intrinsic motivation to participate in epidemiologic surveys? Eur J Epidemiol. 2010;25(4):231–5.PubMedCrossRef
18.
Kristensen P, Bjerkedal T. Dealing with emigration in cohort studies: follow-up of mortality and cancer incidence among Norwegians born between 1967 and 1976. Eur J Epidemiol. 2010;25(3):155–61.PubMedCrossRef
19.
Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, Toren K, et al. Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol. 2010;25(3):163–72.PubMedCrossRef
20.
Tolonen H, Laatikainen T, Helakorpi S, Talala K, Martelin T, Prattala R. Marital status, educational level and household income explain part of the excess mortality of survey non-respondents. Eur J Epidemiol. 2010;25(2):69–76.PubMedCrossRef
21.
Walter S, Tiemeier H. Variable selection: current practice in epidemiological studies. Eur J Epidemiol. 2009;24(12):733–6.PubMedCrossRef
22.
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–67.PubMedCrossRef
23.
Alperovitch A, Bertrand M, Jougla E, Vidal JS, Ducimetiere P, Helmer C, et al. Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur J Epidemiol. 2009;24(11):669–75.PubMedCrossRef
24.
Stolk RP, Hutter I, Wittek RPM. Population ageing research: a family of disciplines. Eur J Epidemiol. 2009;24(11):715–8.PubMedCrossRef
25.
Nur U, Longford NT, Cade JE, Greenwood DC. The impact of handling missing data on alcohol consumption estimates in the UK women cohort study. Eur J Epidemiol. 2009;24(10):589–95.PubMedCrossRef
26.
Hofman A, Breteler MMB, van Duijn CM, Janssen HLA, Krestin GP, Kuipers EJ, et al. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol. 2009;24(9):553–72.PubMedCrossRef
27.
Barakat-Haddad CP, Elliott S, Eyles J, Pengelly D. Predictors of locating children participants in epidemiological studies 20 years after last contact: internet resources and longitudinal research. Eur J Epidemiol. 2009;24(8):397–405.PubMedCrossRef
28.
Merry AHH, Boer JMA, Schouten LJ, Feskens EJM, Verschuren WMM, Gorgels APM, et al. Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in The Netherlands using the cardiovascular registry Maastricht cohort study. Eur J Epidemiol. 2009;24(5):237–47.PubMedCrossRef
29.
Bonneux LGA. Medical demography and epidemiology: dizygotic twins. Eur J Epidemiol. 2009;24(4):157–9.PubMedCrossRef
30.
Lagerros YT, Bellocco R, Adami HO, Nyren O. Measures of physical activity and their correlates: The Swedish National March Cohort. Eur J Epidemiol. 2009;24(4):161–9.PubMedCrossRef
31.
Jacobi D, Charles MA, Tafflet M, Lommez A, Borys JM, Oppert JM. Relationships of self-reported physical activity domains with accelerometry recordings in French adults. Eur J Epidemiol. 2009;24(4):171–9.PubMedCrossRef
32.
Lagerros Y. Physical activity-the more we measure, the more we know how to measure. Eur J Epidemiol. 2009;24(3):119–22.PubMedCrossRef
33.
de Torbal A, Boersma E, Kors JA, van Herpen G, Deckers JW, van der Kuip DA, et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J. 2006;27(6):729–36.PubMedCrossRef
34.
Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270–8.PubMed
35.
Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, et al. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam Study. Hypertension. 2010;55(3):785–91.PubMedCrossRef
36.
Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J. 2006;27(11):1331–7.PubMedCrossRef
37.
Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111(5):570–5.PubMedCrossRef
38.
van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, et al. Tissue plasminogen activator and risk of myocardial infarction: the Rotterdam Study. Circulation. 1997;95(12):2623–7.PubMed
39.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432–7.PubMed
40.
Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657–63.PubMedCrossRef
41.
Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112(4):572–7.PubMedCrossRef
42.
van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109(9):1089–94.PubMedCrossRef
43.
Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam Study. J Am Coll Cardiol. 2010;56(17):1407–14.PubMedCrossRef
44.
Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, et al. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol. 2006;47(8):1568–75.PubMedCrossRef
45.
Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(1):73–80.PubMedCrossRef
46.
Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953–61.PubMedCrossRef
47.
Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 2009;41(6):712–7.PubMedCrossRef
48.
Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet. 2009;41(11):1191–8.PubMedCrossRef
49.
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41(6):677–87.PubMedCrossRef
50.
Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Meta-analysis of genome-wide association studies in >80,000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123(7):731–8.PubMedCrossRef
51.
Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382–92.PubMedCrossRef
52.
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: the Rotterdam Study. Eur Heart J. 2004;25(18):1614–9.PubMedCrossRef
53.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam Study. Eur Heart J. 2006;27(8):949–53.PubMedCrossRef
54.
van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, et al. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam Study. Eur Heart J. 2006;27(19):2346–52.PubMedCrossRef
55.
Heeringa J, Kors JA, Hofman A, van Rooij FJ, Witteman JC. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J. 2008;156(6):1163–9.PubMedCrossRef
56.
Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med. 2008;168(20):2219–24.PubMedCrossRef
57.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Rooij FJ, Lip GY, et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med. 2007;167(4):382–7.PubMedCrossRef
58.
Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, et al. Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA. 2009;302(2):168–78.PubMedCrossRef
59.
Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV, et al. Genome-wide association study of PR interval. Nat Genet. 2010;42(2):153–9.PubMedCrossRef
60.
Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009;41(8):879–81.PubMedCrossRef
61.
Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes. 2007;56(3):872–8.PubMedCrossRef
62.
Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362–7.PubMedCrossRef
63.
Kardys I, Deckers JW, Stricker BH, Vletter WB, Hofman A, Witteman J. Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol. 2010;25(7):481–90.PubMedCrossRef
64.
Bellocco R, Jia CQ, Ye WM, Lagerros YT. Effects of physical activity, body mass index, waist-to-hip ratio and waist circumference on total mortality risk in the Swedish National March Cohort. Eur J Epidemiol. 2010;25(11):777–88.PubMedCrossRef
65.
Lindman AS, Veierod MB, Tverdal A, Pedersen JI, Selmer R. Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study. Eur J Epidemiol. 2010;25(11):789–98.PubMedCrossRef
66.
Alberts VP, Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Stricker BHC, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol. 2010;25(11):807–12.PubMedCrossRef
67.
Geelhoed JJM, Jaddoe VWV. Early influences on cardiovascular and renal development. Eur J Epidemiol. 2010;25(10):677–92.PubMedCrossRef
68.
Daniel M, Paquet C, Auger N, Zang G, Kestens Y. Association of fast-food restaurant and fruit and vegetable store densities with cardiovascular mortality in a metropolitan population. Eur J Epidemiol. 2010;25(10):711–9.PubMedCrossRef
69.
Waller K, Kujala UM, Rantanen T, Kauppinen M, Silventoinen K, Koskenvuo M, et al. Physical activity, morbidity and mortality in twins: a 24-year prospective follow-up. Eur J Epidemiol. 2010;25(10):731–9.PubMedCrossRef
70.
Kallberg H, Alfredsson L, Feychting M, Ahlbom A. Do split your epidemiological data reply. Eur J Epidemiol. 2010;25(10):760.
71.
Savela S, Koistinen P, Tilvis RS, Strandberg AY, Pitkala KH, Salomaa VV, et al. Leisure-time physical activity, cardiovascular risk factors and mortality during a 34-year follow-up in men. Eur J Epidemiol. 2010;25(9):619–25.PubMedCrossRef
72.
Carlsson AC, Theobald H, Wandell PE. Health factors and longevity in men and women: a 26-year follow-up study. Eur J Epidemiol. 2010;25(8):547–51.PubMedCrossRef
73.
Kettaneh A, Fardet L, Mario N, Retbi A, Taright N, Tiev K, et al. The 2003 heat wave in France: hydratation status changes in older inpatients. Eur J Epidemiol. 2010;25(7):517–24.PubMedCrossRef
74.
75.
Thomas C, Power C. Shift work and risk factors for cardiovascular disease: a study at age 45 years in the 1958 British birth cohort. Eur J Epidemiol. 2010;25(5):305–14.PubMedCrossRef
76.
Hublin C, Partinen M, Koskenvuo K, Silventoinen K, Koskenvuo M, Kaprio J. Shift-work and cardiovascular disease: a population-based 22-year follow-up study. Eur J Epidemiol. 2010;25(5):315–23.PubMedCrossRef
77.
Alatupa S, Pulkki-Raback L, Hintsanen M, Ravaja N, Raitakari OT, Telama R, et al. School performance as a predictor of adulthood obesity: a 21-year follow-up study. Eur J Epidemiol. 2010;25(4):267–74.PubMedCrossRef
78.
Kvamme JM, Wilsgaard T, Florholmen J, Jacobsen BK. Body mass index and disease burden in elderly men and women: the Tromso Study. Eur J Epidemiol. 2010;25(3):183–93.PubMedCrossRef
79.
Schaeffner ES, van der Giet M, Gaedeke J, Tolle M, Ebert N, Kuhlmann MK, et al. The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol. 2010;25(3):203–10.PubMedCrossRef
80.
Bonneux LG, Huisman CC, de Beer JA. Mortality in 272 European regions, 2002–2004. An update. Eur J Epidemiol. 2010;25(2):77–85.PubMedCrossRef
81.
Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25(2):95–102.PubMedCrossRef
82.
van Noord C, Dorr M, Sturkenboom M, Straus S, Reffelmann T, Felix SB, et al. The association of serum testosterone levels and ventricular repolarization. Eur J Epidemiol. 2010;25(1):21–8.PubMedCrossRef
83.
84.
85.
Gulsvik AK, Thelle DS, Mowe M, Wyller TB. Increased mortality in the slim elderly: a 42 years follow-up study in a general population. Eur J Epidemiol. 2009;24(11):683–90.PubMedCrossRef
86.
Wiesbauer F, Blessberger H, Goliasch G, Holy EW, Pfaffenberger S, Tentzeris I, et al. Elevated risk of myocardial infarction in very young immigrants from former Yugoslavia. Eur J Epidemiol. 2009;24(11):691–6.PubMedCrossRef
87.
Gasparrini A, Gorini G, Barchielli A. On the relationship between smoking bans and incidence of acute myocardial infarction. Eur J Epidemiol. 2009;24(10):597–602.PubMedCrossRef
88.
Setia MS, Quesnel-Vallee A, Abrahamowicz M, Tousignant P, Lynch J. Convergence of body mass index of immigrants to the Canadian-born population: evidence from the National Population Health Survey (1994–2006). Eur J Epidemiol. 2009;24(10):611–23.PubMedCrossRef
89.
Rey G, Fouillet A, Bessemoulin P, Frayssinet P, Dufour A, Jougla E, et al. Heat exposure and socio-economic vulnerability as synergistic factors in heat-wave-related mortality. Eur J Epidemiol. 2009;24(9):495–502.PubMedCrossRef
90.
Regidor E, Astasio P, Calle ME, Martinez D, Ortega P, Dominguez V. The association between birthplace in different regions of the world and cardiovascular mortality among residents of Spain. Eur J Epidemiol. 2009;24(9):503–12.PubMedCrossRef
91.
Hertel S, Le Tertre A, Jockel KH, Hoffmann B. Quantification of the heat wave effect on cause-specific mortality in Essen, Germany. Eur J Epidemiol. 2009;24(8):407–14.PubMedCrossRef
92.
Chimonas T, Fanouraki I, Liberopoulos EN, Chimonas E, Elisaf M. Diverging trends in cardiovascular morbidity and mortality in a low risk population. Eur J Epidemiol. 2009;24(8):415–23.PubMedCrossRef
93.
Oliveira A, Barros H, Azevedo A, Bastos J, Lopes C. Impact of risk factors for non-fatal acute myocardial infarction. Eur J Epidemiol. 2009;24(8):425–32.PubMedCrossRef
94.
Schlaefer K, Schlehofer B, Schuz J. Validity of self-reported occupational noise exposure. Eur J Epidemiol. 2009;24(8):469–75.PubMedCrossRef
95.
Mayer O, Simon J, Plaskova M, Cifkova R, Trefil L. N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure. Eur J Epidemiol. 2009;24(7):363–8.PubMedCrossRef
96.
Pearce MS, Relton CL, Parker L, Unwin NC. Sex differences in the association between infant feeding and blood cholesterol in later life: the Newcastle thousand families cohort study at age 49–51 years. Eur J Epidemiol. 2009;24(7):375–80.PubMedCrossRef
97.
Dorr M, Wallaschofski H, Friedrich N. Association of low total testosterone levels and prevalent carotid plaques: result of the study of health in Pomerania. Eur J Epidemiol. 2009;24(7):389–91.PubMedCrossRef
98.
Corpeleijn E, Bakker SJL, Stolk RP. Obesity and impaired renal function: potential for lifestyle intervention? Eur J Epidemiol. 2009;24(6):275–80.PubMedCrossRef
99.
Vikan T, Johnsen SH, Schirmer H, Njolstad I, Svartberg J. Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur J Epidemiol. 2009;24(6):289–95.PubMedCrossRef
100.
Fallah N, Mohammad K, Nourijelyani K, Eshraghian MR, Seyyedsalehi SA, Raiessi M, et al. Nonlinear association between serum testosterone levels and coronary artery disease in Iranian men. Eur J Epidemiol. 2009;24(6):297–306.PubMedCrossRef
101.
Ruan LT, Chen W, Srinivasan S, Xu JH, Toprak A, Berenson G. Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. Eur J Epidemiol. 2009;24(6):315–9.PubMedCrossRef
102.
Saleheen D, Zaidi M, Rasheed A, Ahmad U, Hakeem A, Murtaza M, et al. The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia. Eur J Epidemiol. 2009;24(6):329–38.PubMedCrossRef
103.
Tasevska-Dinevska G, Kennedy LMA, Nilsson PM, Willenheimer R. Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmo preventive project. Eur J Epidemiol. 2009;24(5):249–57.PubMedCrossRef
104.
Zheng H, Orsini N, Amin J, Wolk A, Nguyen VTT, Ehrlich F. Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis. Eur J Epidemiol. 2009;24(4):181–92.PubMedCrossRef
105.
Greiser KH, Kluttig A, Schumann B, Swenne CA, Kors JA, Kuss O, et al. Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002–2006. Eur J Epidemiol. 2009;24(3):123–42.PubMedCrossRef
106.
Jaffe DH, Neumark YD, Eisenbach Z, Manor O. Parity-related mortality: shape of association among middle-aged and elderly men and women. Eur J Epidemiol. 2009;24(1):9–16.PubMedCrossRef
107.
Dragano N, Hoffmann B, Stang A, Moebus S, Verde PE, Weyers S, et al. Subclinical coronary atherosclerosis and neighbourhood deprivation in an urban region. Eur J Epidemiol. 2009;24(1):25–35.PubMedCrossRef
108.
Osler M, Lund R, Kriegbaum M, Andersen AMN. The influence of birth weight and body mass in early adulthood on early coronary heart disease risk among Danish men born in 1953. Eur J Epidemiol. 2009;24(1):57–61.PubMedCrossRef
109.
Klenk J, Nagel G, Ulmer H, Strasak A, Concin H, Diem G, et al. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol. 2009;24(2):83–91.PubMedCrossRef
110.
Turin TC, Kita Y, Rumana N, Sugihara H, Morita Y, Tomioka N, et al. Incidence, admission and case-fatality of acute myocardial infarction: weekend versus weekday in a Japanese population: 16-year results from Takashima AMI Registry (1988–2003). Eur J Epidemiol. 2009;24(2):93–100.PubMedCrossRef
111.
Zhang HL, Yang Y, Wu JA. Can prevalence of apolipoprotein E epsilon 4 allele explain the geographical variation of coronary heart disease mortality rates in Western Europe? Eur J Epidemiol. 2010;25(12):897–8.PubMedCrossRef
112.
Kiiski V, de Vries E, Flohil SC, Bijl MJ, Hofman A, Stricker BH, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol. 2010;146(8):848–55.PubMedCrossRef
113.
Flohil SC, de Vries E, van Meurs JB, Fang Y, Stricker BH, Uitterlinden AG, et al. Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas. Exp Dermatol. 2010;19(12):1103–5.PubMedCrossRef
114.
Odding E, Valkenburg HA, Stam HJ, Hofman A. Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study. Eur J Epidemiol. 2001;17(11):1033–41.PubMedCrossRef
115.
Tas U, Verhagen AP, Bierma-Zeinstra SM, Hofman A, Odding E, Pols HA, et al. Incidence and risk factors of disability in the elderly: the Rotterdam Study. Prev Med. 2007;44(3):272–8.PubMedCrossRef
116.
Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res. 2002;17(6):1051–6.PubMedCrossRef
117.
Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34(1):195–202.PubMedCrossRef
118.
van Daele PL, Burger H, Algra D, Hofman A, Grobbee DE, Birkenhager JC, et al. Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam Study. J Bone Miner Res. 1994;9(11):1751–7.PubMedCrossRef
119.
van Daele PL, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JP, et al. Case–control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam Study. BMJ. 1996;312(7029):482–3.PubMed
120.
Goderie-Plomp HW, van der Klift M, de Ronde W, Hofman A, de Jong FH, Pols HA. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. J Clin Endocrinol Metab. 2004;89(7):3261–9.PubMedCrossRef
121.
van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350(20):2033–41.PubMedCrossRef
122.
Bergink AP, Uitterlinden AG, Van Leeuwen JP, Hofman A, Verhaar JA, Pols HA. Bone mineral density and vertebral fracture history are associated with incident and progressive radiographic knee osteoarthritis in elderly men and women: the Rotterdam Study. Bone. 2005;37(4):446–56.PubMedCrossRef
123.
van der Klift M, de Laet CE, Coebergh JW, Hofman A, Pols HA, Rotterdam S. Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone. 2003;32(3):211–6.PubMedCrossRef
124.
van der Klift M, Pols HA, Hak AE, Witteman JC, Hofman A, de Laet CE. Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study. Calcif Tissue Int. 2002;70(6):443–9.PubMedCrossRef
125.
van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, et al. Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med. 1995;122(6):409–14.PubMed
126.
de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16(12):1713–20.PubMedCrossRef
127.
van der Klift M, de Laet CD, Pols HA. Assessment of fracture risk: who should be treated for osteoporosis? Best Pract Res Clin Rheumatol. 2005;19(6):937–50.PubMedCrossRef
128.
de Laet CE, van der Klift M, Hofman A, Pols HA. Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res. 2002;17(12):2231–6.PubMedCrossRef
129.
De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16(11):1330–8.PubMedCrossRef
130.
Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum. 2004;50(8):2471–8.PubMedCrossRef
131.
Reijman M, Hazes JM, Pols HA, Bernsen RM, Koes BW, Bierma-Zeinstra SM. Validity and reliability of three definitions of hip osteoarthritis: cross sectional and longitudinal approach. Ann Rheum Dis. 2004;63(11):1427–33.PubMedCrossRef
132.
Reijman M, Hazes JM, Pols HA, Bernsen RM, Koes BW, Bierma-Zeinstra SM. Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study. BMJ. 2005;330(7501):1183.PubMedCrossRef
133.
Brouwer GM, van Tol AW, Bergink AP, Belo JN, Bernsen RM, Reijman M, et al. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum. 2007;56(4):1204–11.PubMedCrossRef
134.
Dahaghin S, Bierma-Zeinstra SM, Reijman M, Pols HA, Hazes JM, Koes BW. Does hand osteoarthritis predict future hip or knee osteoarthritis? Arthritis Rheum. 2005;52(11):3520–7.PubMedCrossRef
135.
Hak AE, Pols HA, Stehouwer CD, Meijer J, Kiliaan AJ, Hofman A, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam Study. J Clin Endocrinol Metab. 2001;86(9):4398–405.PubMedCrossRef
136.
Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia: the Rotterdam Study. Clin Endocrinol (Oxf). 2000;53(6):733–7.CrossRef
137.
Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, Lindemans J, et al. A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab. 2005;90(9):5313–6.PubMedCrossRef
138.
Rivadeneira F, van Meurs JB, Kant J, Zillikens MC, Stolk L, Beck TJ, et al. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res. 2006;21(9):1443–56.PubMedCrossRef
139.
Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, Janssen JA, Hofman A, Pols HA, et al. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res. 2004;19(8):1280–90.PubMedCrossRef
140.
van Rossum EF, Koper JW, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes. 2002;51(10):3128–34.PubMedCrossRef
141.
den Heijer T, Schuit SC, Pols HA, van Meurs JB, Hofman A, Koudstaal PJ, et al. Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. Mol Psychiatry. 2004;9(12):1129–35.CrossRef
142.
Beck TJ, Ruff CB, Warden KE, Scott WW Jr, Rao GU. Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol. 1990;25(1):6–18.PubMedCrossRef
143.
McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int. 1993;3(3):138–47.PubMedCrossRef
144.
Jansson KA, Blomqvist P, Svedmark P, Granath F, Buskens E, Larsson M, et al. Thoracolumbar vertebral fractures in Sweden: an analysis of 13,496 patients admitted to hospital. Eur J Epidemiol. 2010;25(6):431–7.PubMedCrossRef
145.
Schuur M, Henneman P, van Swieten JC, Zillikens MC, de Koning I, Janssens A, et al. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol. 2010;25(8):561–8.PubMedCrossRef
146.
Forsen L, Berntsen GK, Meyer HE, Tell GS, Fonnebo V, Group NCR. Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study. Eur J Epidemiol. 2008;23(9):615–24.PubMedCrossRef
147.
Yaegashi Y, Onoda T, Tanno K, Kuribayashi T, Sakata K, Orimo H. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K. Eur J Epidemiol. 2008;23(3):219–25.PubMedCrossRef
148.
Siggeirsdottir K, Aspelund T, Sigurdsson G, Mogensen B, Chang M, Jonsdottir B, et al. Inaccuracy in self-report of fractures may underestimate association with health outcomes when compared with medical record based fracture registry. Eur J Epidemiol. 2007;22(9):631–9.PubMedCrossRef
149.
Yang YJ, Wang YB, Lei SF, Long JR, Shen H, Zhao LJ, et al. AHSG gene polymorphisms are associated with bone mineral density in Caucasian nuclear families. Eur J Epidemiol. 2007;22(8):527–32.PubMedCrossRef
150.
Hong X, Niu T, Chen C, Wang B, Venners SA, Fang Z, et al. Familial aggregation of forearm bone mineral density in Chinese. Eur J Epidemiol. 2007;22(5):335–41.PubMedCrossRef
151.
Piirtola M, Vahlberg T, Lopponen M, Raiha I, Isoaho R, Kivela SL. Fractures as predictors of excess mortality in the aged-a population-based study with a 12-year follow-up. Eur J Epidemiol. 2008;23(11):747–55.PubMedCrossRef
152.
Wallensten A, Oliver I, Ricketts K, Kafatos G, Stuart JM, Joseph C. Windscreen wiper fluid without added screenwash in motor vehicles: a newly identified risk factor for Legionnaires’ disease. Eur J Epidemiol. 2010;25(9):661–5.PubMedCrossRef
153.
Hui WS, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol. 2010;25(6):375–84.PubMedCrossRef
154.
Kowall B, Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, et al. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol. 2010;25(6):393–402.PubMedCrossRef
155.
Morseth B, Emaus N, Wilsgaard T, Jacobsen BK, Jorgensen L. Leisure time physical activity in adulthood is positively associated with bone mineral density 22 years later. The Tromso study. Eur J Epidemiol. 2010;25(5):325–31.PubMedCrossRef
156.
Kataja-Tuomola M, Sundell J, Mannisto S, Virtanen MJ, Kontto J, Albanes D, et al. Short-term weight change and fluctuation as risk factors for type 2 diabetes in Finnish male smokers. Eur J Epidemiol. 2010;25(5):333–9.PubMedCrossRef
157.
Nagaya T, Yoshida H, Takahashi H, Kawai M. Heart rate-corrected QT interval in resting ECG predicts the risk for development of type-2 diabetes mellitus. Eur J Epidemiol. 2010;25(3):195–202.PubMedCrossRef
158.
Laaksonen MA, Knekt P, Rissanen H, Harkanen T, Virtala E, Marniemi J, et al. The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol. 2010;25(2):115–24.PubMedCrossRef
159.
Bot M, Spijkerman AMW, Twisk JWR, Verschuren WMM. Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort. Eur J Epidemiol. 2010;25(2):125–33.PubMedCrossRef
160.
Qin L, Knol MJ, Corpeleijn E, Stolk RP. Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data. Eur J Epidemiol. 2010;25(1):5–12.PubMedCrossRef
161.
Manda SOM, Feltbower RG, Gilthorpe MS. Investigating spatio-temporal similarities in the epidemiology of childhood leukaemia and diabetes. Eur J Epidemiol. 2009;24(12):743–52.PubMedCrossRef
162.
Bruyere O, Varela AR, Adami S, Detilleux J, Rabenda V, Hiligsmann M, et al. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women. Eur J Epidemiol. 2009;24(11):707–12.PubMedCrossRef
163.
Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study. Eur J Epidemiol. 2009;24(9):537–9.PubMedCrossRef
164.
Ahmed LA, Schirmer H, Bjornerem A, Emaus N, Jorgensen L, Stormer J, et al. The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromso, Norway. Eur J Epidemiol. 2009;24(8):441–8.PubMedCrossRef
165.
Sylliaas H, Idland G, Sandvik L, Forsen L, Bergland A. Does mortality of the aged increase with the number of falls? Results from a nine-year follow-up study. Eur J Epidemiol. 2009;24(7):351–5.PubMedCrossRef
166.
Bloch F, Jegou D, Dhainaut JF, Rigaud AS, Coste J, Lundy JE, et al. Can metabolic abnormalities after a fall predict short term mortality in elderly patients? Eur J Epidemiol. 2009;24(7):357–62.PubMedCrossRef
167.
Sabanayagam C, Shankar A, Li JL, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol. 2009;24(7):369–73.PubMedCrossRef
168.
Olafsdottir E, Aspelund T, Sigurdsson G, Thorsson B, Benediktsson R, Harris TB, et al. Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik). Eur J Epidemiol. 2009;24(6):307–14.PubMedCrossRef
169.
Emaus N, Omsland TK, Ahmed LA, Grimnes G, Sneve M, Berntsen GK. Bone mineral density at the hip in Norwegian women and men-prevalence of osteoporosis depends on chosen references: the Tromso Study. Eur J Epidemiol. 2009;24(6):321–8.PubMedCrossRef
170.
Moayyeri A, Kaptoge S, Luben RN, Wareham NJ, Bingham S, Reeve J, et al. Estimation of absolute fracture risk among middle-aged and older men and women: the EPIC-Norfolk population cohort study. Eur J Epidemiol. 2009;24(5):259–66.PubMedCrossRef
171.
Balk L, Hoekstra T, Twisk J. Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol. 2009;24(4):203–9.PubMedCrossRef
172.
de Sousa AGP, Pereira AC, Marquezine GF, do Nascimento-Neto RM, Freitas S, Nicolato RLD, et al. Derivation and external validation of a simple prediction model for the diagnosis of type 2 Diabetes Mellitus in the Brazilian urban population. Eur J Epidemiol. 2009;24(2):101–9.CrossRef
173.
Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708–15.PubMedCrossRef
174.
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.PubMedCrossRef
175.
Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214–20.PubMedCrossRef
176.
Santibanez M, Vioque J, Alguacil J, de la Hera MG, Moreno-Osset E, Carrato A, et al. Occupational exposures and risk of pancreatic cancer. Eur J Epidemiol. 2010;25(10):721–30.PubMedCrossRef
177.
Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, et al. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010;25(10):741–50.PubMedCrossRef
178.
Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25(7):439–48.PubMedCrossRef
179.
Schmeisser N, Conway DI, McKinney PA, McMahon AD, Pohlabeln H, Marron M, et al. Life course social mobility and risk of upper aerodigestive tract cancer in men. Eur J Epidemiol. 2010;25(3):173–82.PubMedCrossRef
180.
Schmassmann A, Oldendorf MG, Gebbers JO. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol. 2009;24(10):603–9.PubMedCrossRef
181.
Asfeldt AM, Steigen SE, Lochen ML, Straume B, Johnsen R, Bernersen B, et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sorreisa gastrointestinal disorder study. Eur J Epidemiol. 2009;24(10):649–58.PubMedCrossRef
182.
Erichsen R, Jepsen P, Vilstrup H, Ekbom A, Sorensen HT. Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978–2003. Eur J Epidemiol. 2009;24(9):513–20.PubMedCrossRef
183.
Watanabe H, Kamijima Y, Sato T, Kaufman DW, Kubota K. Ex-drinking may be a surrogate for unmeasured risk factors for upper gastrointestinal bleeding: reappraisal and an additional survey of subjects from a case–control study in Japan. Eur J Epidemiol. 2009;24(3):143–7.PubMedCrossRef
184.
Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer’s disease and vascular dementia: association with education: the Rotterdam Study. BMJ. 1995;310(6985):970–3.PubMed
185.
de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al. Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143–6.PubMed
186.
Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population: the Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74(3):317–21.PubMedCrossRef
187.
Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575–80.PubMedCrossRef
188.
de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63(7):1240–4.PubMed
189.
Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308(6944):1604–8.PubMed
190.
Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349(9046):151–4.PubMedCrossRef
191.
Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, et al. Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998;351(9119):1840–3.PubMedCrossRef
192.
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287(24):3223–9.PubMedCrossRef
193.
Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002;359(9303):281–6.PubMedCrossRef
194.
int’ Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med. 2001;345(21):1515–21.CrossRef
195.
Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, et al. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes. 2010;59(7):1601–7.PubMedCrossRef
196.
Euser SM, van Bemmel T, Schram MT, Gussekloo J, Hofman A, Westendorp RG, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc. 2009;57(7):1232–7.PubMedCrossRef
197.
Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grobbee DE, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam Study. Circulation. 2002;105(24):2872–7.PubMedCrossRef
198.
Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114(15):1591–8.PubMedCrossRef
199.
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–22.PubMedCrossRef
200.
Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832–40.PubMedCrossRef
201.
Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genomewide association studies of stroke. N Engl J Med. 2009;360(17):1718–28.PubMedCrossRef
202.
Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821–8.PubMedCrossRef
203.
Killgore WD, Glahn DC, Casasanto DJ. Development and validation of the design organization test (DOT): a rapid screening instrument for assessing visuospatial ability. J Clin Exp Neuropsychol. 2005;27(4):449–59.PubMedCrossRef
204.
Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.PubMedCrossRef
205.
Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44(7):1246–52.PubMed
206.
Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry. 2009;66(5):545–53.PubMedCrossRef
207.
Sellier E, Surman G, Himmelmann K, Andersen G, Colver A, Krageloh-Mann I, et al. Trends in prevalence of cerebral palsy in children born with a birthweight of 2,500 g or over in Europe from 1980 to 1998. Eur J Epidemiol. 2010;25(9):635–42.PubMedCrossRef
208.
Heys M, Jiang CQ, Schooling CM, Zhang WS, Cheng KK, Lam TH, et al. Is childhood meat eating associated with better later adulthood cognition in a developing population? Eur J Epidemiol. 2010;25(7):507–16.PubMedCrossRef
209.
Risselada R, Lingsma HF, Bauer-Mehren A, Friedrich CM, Molyneux AJ, Kerr RSC, et al. Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT). Eur J Epidemiol. 2010;25(4):261–6.PubMedCrossRef
210.
Kerneis S, Boelle PY, Grais RF, Pavillon G, Jougla E, Flahault A, et al. Mortality trends in systemic sclerosis in France and USA, 1980–1998: an age-period-cohort analysis. Eur J Epidemiol. 2010;25(1):55–61.PubMedCrossRef
211.
Alonso A. Diagnostic validity of hospital discharge codes in the ascertainment of amyotrophic lateral sclerosis. Eur J Epidemiol. 2010;25(1):63.PubMedCrossRef
212.
Pisa FE, Verriello L, Deroma L, Drigo D, Bergonzi P, Gigli GL, et al. The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital. Eur J Epidemiol. 2009;24(10):635–40.PubMedCrossRef
213.
Ahlgren C, Toren K, Oden A, Andersen O. A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol. 2009;24(9):541–52.PubMedCrossRef
214.
Berg-Beckhoff G, Schuz J, Blettner M, Munster E, Schlaefer K, Wahrendorf J, et al. History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol. 2009;24(8):433–40.PubMedCrossRef
215.
Baas DC, Ho L, Ennis S, Merriam JE, Tanck MW, Uitterlinden AG, et al. The complement component 5 gene and age-related macular degeneration. Ophthalmology. 2010;117(3):500–11.PubMedCrossRef
216.
Baas DC, Despriet DD, Gorgels TG, Bergeron-Sawitzke J, Uitterlinden AG, Hofman A, et al. The ERCC6 gene and age-related macular degeneration. PLoS One. 2010;5(11):e13786.PubMedCrossRef
217.
Allikmets R, Dean M, Hageman GS, Baird PN, Klaver CC, Bergen AA, et al. The SERPING1 gene and age-related macular degeneration. Lancet. 2009;374(9693):875–6 (author reply 6–7).PubMedCrossRef
218.
Allikmets R, Bergen AA, Dean M, Guymer RH, Hageman GS, Klaver CC, et al. Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med. 2009;360(21):2252–4 (author reply 5–6).PubMed
219.
Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and {omega}-3 fatty acids: the Rotterdam Study. Arch Ophthalmol. 2011;129(6):758–66.PubMedCrossRef
220.
Ramdas WD, van Koolwijk LM, Ikram MK, Jansonius NM, de Jong PT, Bergen AA, et al. A genome-wide association study of optic disc parameters. PLoS Genet. 2010;6(6):e1000978.PubMedCrossRef
221.
Ramdas WD, van Koolwijk LM, Lemij HG, Pasutto F, Cree AJ, Thorleifsson G, et al. Common genetic variants associated with open-angle glaucoma. Hum Mol Genet. 2011;20(12):2464–71.PubMedCrossRef
222.
Ramdas WD, Amin N, van Koolwijk LM, Janssens AC, Demirkan A, de Jong PT, et al. Genetic architecture of open angle glaucoma and related determinants. J Med Genet. 2011;48(3):190–6.PubMedCrossRef
223.
Ramdas WD, Wolfs RC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. Lifestyle and risk of developing open-angle glaucoma: the Rotterdam Study. Arch Ophthalmol. 2011;129(6):767–72.PubMedCrossRef
224.
Solouki AM, Verhoeven VJ, van Duijn CM, Verkerk AJ, Ikram MK, Hysi PG, et al. A genome-wide association study identifies a susceptibility locus for refractive errors and myopia at 15q14. Nat Genet. 2010;42(10):897–901.PubMedCrossRef
225.
Hysi I, Wattez H, Benhamed L, Porte H. Primary pulmonary myoepithelial carcinoma. Interact Cardiovasc Thorac Surg. 2011.
226.
Ikram MK, Sim X, Jensen RA, Cotch MF, Hewitt AW, Ikram MA, et al. Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet. 2010;6(10):e1001184.PubMedCrossRef
227.
de Jong FJ, Schrijvers EM, Ikram MK, Koudstaal PJ, de Jong PT, Hofman A, et al. Retinal vascular caliber and risk of dementia: the Rotterdam Study. Neurology. 2011;76(9):816–21.PubMedCrossRef
228.
Wieberdink RG, Ikram MK, Koudstaal PJ, Hofman A, Vingerling JR, Breteler MM. Retinal vascular calibers and the risk of intracerebral hemorrhage and cerebral infarction: the Rotterdam Study. Stroke. 2010;41(12):2757–61.PubMedCrossRef
229.
Ikram MK, Luijendijk HJ, Hofman A, de Jong PT, Breteler MM, Vingerling JR, et al. Retinal vascular calibers and risk of late-life depression: the Rotterdam Study. Am J Geriatr Psychiatry. 2010;18(5):452–5.PubMedCrossRef
230.
Tiemeier H, van Dijck W, Hofman A, Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry. 2004;61(4):369–76.PubMedCrossRef
231.
Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr. 2003;78(1):40–6.PubMed
232.
Dekker MJ, Koper JW, van Aken MO, Pols HA, Hofman A, de Jong FH, et al. Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab. 2008;93(10):3741–7.PubMedCrossRef
233.
Ikram MA, Luijendijk HJ, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, et al. Vascular brain disease and depression in the elderly. Epidemiology. 2010;21(1):78–81.PubMedCrossRef
234.
Krijthe BP, Walter S, Newson RS, Hofman A, Hunink MG, Tiemeier H. Is positive affect associated with survival? A population-based study of elderly persons. Am J Epidemiol. 2011;173(11):1298–307.PubMedCrossRef
235.
van den Berg JF, Knvistingh Neven A, Tulen JH, Hofman A, Witteman JC, Miedema HM, et al. Actigraphic sleep duration and fragmentation are related to obesity in the elderly: the Rotterdam Study. Int J Obes (Lond). 2008;32(7):1083–90.CrossRef
236.
Luijendijk HJ, van den Berg JF, Dekker MJ, van Tuijl HR, Otte W, Smit F, et al. Incidence and recurrence of late-life depression. Arch Gen Psychiatry. 2008;65(12):1394–401.PubMedCrossRef
237.
Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. SCAN: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589–93.PubMed
238.
Wittchen HU, Lachner G, Wunderlich U, Pfister H. Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol. 1998;33(11):568–78.PubMedCrossRef
239.
van den Berg JF, Luijendijk HJ, Tulen JH, Hofman A, Neven AK, Tiemeier H. Sleep in depression and anxiety disorders: a population-based study of elderly persons. J Clin Psychiatry. 2009;70(8):1105–13.PubMedCrossRef
240.
Van Den Berg JF, Van Rooij FJ, Vos H, Tulen JH, Hofman A, Miedema HM, et al. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res. 2008;17(3):295–302.CrossRef
241.
Prigerson HG, Maciejewski PK, Reynolds CF 3rd, Bierhals AJ, Newsom JT, Fasiczka A, et al. Inventory of complicated grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res. 1995;59(1–2):65–79.PubMedCrossRef
242.
Naarding P, Tiemeier H, Breteler MM, Schoevers RA, Jonker C, Koudstaal PJ, et al. Clinically defined vascular depression in the general population. Psychol Med. 2007;37(3):383–92.PubMedCrossRef
243.
Newson RS, Hek K, Luijendijk HJ, Hofman A, Witteman JC, Tiemeier H. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry. 2010;67(11):1144–51.PubMedCrossRef
244.
van den Berg JF, Miedema HM, Tulen JH, Neven AK, Hofman A, Witteman JC, et al. Long sleep duration is associated with serum cholesterol in the elderly: the Rotterdam Study. Psychosom Med. 2008;70(9):1005–11.PubMedCrossRef
245.
van den Berg JF, Miedema HM, Tulen JH, Hofman A, Neven AK, Tiemeier H. Sex differences in subjective and actigraphic sleep measures: a population-based study of elderly persons. Sleep. 2009;32(10):1367–75.PubMed
246.
Hek K. Anxiety disorders and comorbid depression in community dwelling older adults. Int J Methods Psychiatr Res. (Accepted).
247.
Tobacco, genetics C. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010;42(5):441–7.
248.
Omidvar M, Stolk L, Uitterlinden AG, Hofman A, Van Duijn CM, Tiemeier H. The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study. Pharmacogenet Genomics. 2009;19(1):45–51.PubMedCrossRef
249.
Newson RS, Boelen PA, Hek K, Hofman A, Tiemeier H. The prevalence and characteristics of complicated grief in older adults. J Affect Disord. 2011;132(1–2):231–8.PubMedCrossRef
250.
Velders FP, Kuningas M, Kumari M, Dekker MJ, Uitterlinden AG, Kirschbaum C, et al. Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology. 2011.
251.
Huisman M, Araya R, Lawlor DA, Ormel J, Verhulst FC, Oldehinkel AJ. Cognitive ability, parental socioeconomic position and internalising and externalising problems in adolescence: findings from two European cohort studies. Eur J Epidemiol. 2010;25(8):569–80.PubMedCrossRef
252.
Oksuzyan A, Crimmins E, Saito Y, O’Rand A, Vaupel JW, Christensen K. Cross-national comparison of sex differences in health and mortality in Denmark, Japan and the US. Eur J Epidemiol. 2010;25(7):471–80.PubMedCrossRef
253.
Lehto SM, Ruusunen A, Niskanen L, Tolmunen T, Voutilainen S, Viinamaki H, et al. Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men. Eur J Epidemiol. 2010;25(6):403–9.PubMedCrossRef
254.
Horn O, Sloggett A, Ploubidis GB, Hull L, Hotopf M, Wessely S, et al. Upward trends in symptom reporting in the UK Armed Forces. Eur J Epidemiol. 2010;25(2):87–94.PubMedCrossRef
255.
Thomas S, Heinrich S, von Kries R, Radon K. Exposure to radio-frequency electromagnetic fields and behavioural problems in Bavarian children and adolescents. Eur J Epidemiol. 2010;25(2):135–41.PubMedCrossRef
256.
Rask CU, Olsen EM, Elberling H, Christensen MF, Ornbol E, Fink P, et al. Functional somatic symptoms and associated impairment in 5–7-year-old children: the Copenhagen Child Cohort 2000. Eur J Epidemiol. 2009;24(10):625–34.PubMedCrossRef
257.
Aarts S, van den Akker M, van Boxtel MPJ, Jolles J, Winkens B, Metsemakers JFM. Diabetes mellitus type II as a risk factor for depression: a lower than expected risk in a general practice setting. Eur J Epidemiol. 2009;24(10):641–8.PubMedCrossRef
258.
McFadden E, Luben R, Khaw KT. Different measures of social class in women and mortality. Eur J Epidemiol. 2009;24(5):231–6.PubMedCrossRef
259.
Turcinov D, Stanley C, Rutherford GW, Novotny TE, Begovac J. Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy. Eur J Epidemiol. 2009;24(5):267–74.PubMedCrossRef
260.
van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam Study. Chest. 2009;135(2):368–77.PubMedCrossRef
261.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.PubMedCrossRef
262.
van Durme YM, Verhamme KM, Aarnoudse AJ, Van Pottelberge GR, Hofman A, Witteman JC, et al. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(5):375–82.PubMedCrossRef
263.
Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45–52.PubMedCrossRef
264.
Van Durme YM, Eijgelsheim M, Joos GF, Hofman A, Uitterlinden AG, Brusselle GG, et al. Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study. Eur Respir J. 2010;36(1):89–95.PubMedCrossRef
265.
Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720–35.PubMedCrossRef
266.
Lawlor DA, Cooper AR, Bain C, Davey Smith G, Irwin A, Riddoch C, et al. Associations of birth size and duration of breast feeding with cardiorespiratory fitness in childhood: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC). Eur J Epidemiol. 2008;23(6):411–22.PubMedCrossRef
267.
Kompauer I, Demmelmair H, Koletzko B, Bolte G, Linseisen J, Heinrich J. Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults. Eur J Epidemiol. 2008;23(3):175–90.PubMedCrossRef
268.
de Luise C, Brimacombe M, Pedersen L, Sorensen HT. Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol. 2008;23(2):115–22.PubMedCrossRef
269.
Hugg T, Ruotsalainen R, Jaakkola MS, Pushkarev V, Jaakkola JJ. Comparison of allergic diseases, symptoms and respiratory infections between Finnish and Russian school children. Eur J Epidemiol. 2008;23(2):123–33.PubMedCrossRef
270.
Rzehak P, Schoefer Y, Wichmann HE, Heinrich J. A prospective study on the association between hay fever among children and incidence of asthma in East Germany. Eur J Epidemiol. 2008;23(1):17–22.PubMedCrossRef
271.
Svartberg J, Schirmer H, Medbo A, Melbye H, Aasebo U. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromso study. Eur J Epidemiol. 2007;22(2):107–12.PubMedCrossRef
272.
Moreno T, Querol X, Alastuey A, Ballester F, Gibbons W. Airborne particulate matter and premature deaths in urban Europe: the new WHO guidelines and the challenge ahead as illustrated by Spain. Eur J Epidemiol. 2007;22(1):1–5.PubMedCrossRef
273.
Lacourt A, Rolland P, Gramond C, Astoul P, Chamming’s S, Ducamp S, et al. Attributable risk in men in two French case–control studies on mesothelioma and asbestos. Eur J Epidemiol. 2010;25(11):799–806.PubMedCrossRef
274.
Neovius K, Rasmussen F, Sundstrom J, Neovius M. Forecast of future premature mortality as a result of trends in obesity and smoking: nationwide cohort simulation study. Eur J Epidemiol. 2010;25(10):703–9.PubMedCrossRef
275.
Hertel S, Viehmann A, Moebus S, Mann K, Brocker-Preuss M, Mohlenkamp S, et al. Influence of short-term exposure to ultrafine and fine particles on systemic inflammation. Eur J Epidemiol. 2010;25(8):581–92.PubMedCrossRef
276.
Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253–60.PubMedCrossRef
277.
McFadden E, Luben R, Wareham N, Bingham S, Khaw KT. How far can we explain the social class differential in respiratory function? A cross-sectional population study of 21,991 men and women from EPIC-Norfolk. Eur J Epidemiol. 2009;24(4):193–201.PubMedCrossRef
278.
279.
Vaux S, Poujol I, Bonmarin I, Levy-Bruhl D, Desenclos JC. Surveillance of lower respiratory tract infections outbreaks in nursing homes in France. Eur J Epidemiol. 2009;24(3):149–55.PubMedCrossRef
280.
Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet. 2002;359(9311):1036–7.PubMedCrossRef
281.
van Meurs JB, Schuit SC, Weel AE, van der Klift M, Bergink AP, Arp PP, et al. Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet. 2003;12(14):1745–54.PubMedCrossRef
282.
Schuit SC, Oei HH, Witteman JC, Geurts van Kessel CH, van Meurs JB, Nijhuis RL, et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA. 2004;291(24):2969–77.PubMedCrossRef
283.
Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006;38(1):3–5.PubMedCrossRef
284.
Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, et al. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004;292(17):2105–14.PubMedCrossRef
285.
Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006;145(4):255–64.PubMed
286.
Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296(3):301–9.PubMedCrossRef
287.
Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, Hofman A, et al. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation. 2007;116(1):10–6.PubMedCrossRef
288.
Fang Y, van Meurs JB, d’Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study. Am J Hum Genet. 2005;77(5):807–23.PubMedCrossRef
289.
Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41(1):25–34.PubMedCrossRef
290.
Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41(1):77–81.PubMedCrossRef
291.
Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41(1):47–55.PubMedCrossRef
292.
Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics. 2007;23(10):1294–6.PubMedCrossRef
293.
in’t Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001;22(3):407–12.PubMedCrossRef
294.
Luijendijk HJ, van den Berg JF, Hofman A, Tiemeier H, Stricker BH. Beta-blockers and the risk of incident depression in the elderly. J Clin Psychopharmacol. 2011;31(1):45–50.PubMedCrossRef
295.
Feenstra J, Heerdink ER, Grobbee DE, Stricker BH. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med. 2002;162(3):265–70.PubMedCrossRef
296.
van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med. 2006;166(9):1016–20.PubMedCrossRef
297.
van den Hondel KE, Eijgelsheim M, Ruiter R, Witteman JC, Hofman A, Stricker BH. Effect of short-term NSAID use on echocardiographic parameters in elderly people: a population-based cohort study. Heart. 2011;97(7):540–3.PubMedCrossRef
298.
van Noord C, Sturkenboom MC, Straus SM, Witteman JC, Stricker BH. Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death. Heart. 2011;97(3):215–20.PubMedCrossRef
299.
Lubitz SA, Sinner MF, Lunetta KL, Makino S, Pfeufer A, Rahman R, et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation. 2010;122(10):976–84.PubMedCrossRef
300.
Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42(3):240–4.PubMedCrossRef
301.
Eijgelsheim M, Newton-Cheh C, Sotoodehnia N, de Bakker PI, Muller M, Morrison AC, et al. Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet. 2010;19(19):3885–94.PubMedCrossRef
302.
Sotoodehnia N, Isaacs A, de Bakker PI, Dorr M, Newton-Cheh C, Nolte IM, et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010;42(12):1068–76.PubMedCrossRef
303.
Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139(6):476–82.PubMed
304.
Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res. 2004;19(9):1525–30.PubMedCrossRef
305.
Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Stricker BH, Hazes JM. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum. 2005;52(10):3137–42.PubMedCrossRef
306.
van Leeuwen R, Vingerling JR, de Jong PT. Risk of macular degeneration with statin use should be interpreted with caution. BMJ. 2001;323(7324):1308.PubMedCrossRef
307.
van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ. 2003;326(7383):255–6.PubMedCrossRef
308.
Visser LE, Penning-van Beest FJ, Kasbergen AA, De Smet PA, Vulto AG, Hofman A, et al. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants. Clin Pharmacol Ther. 2002;71(6):496–502.PubMedCrossRef
309.
Visser LE, Penning-van Bees FJ, Kasbergen AA, De Smet PA, Vulto AG, Hofman A, et al. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost. 2002;88(5):705–10.PubMed
310.
Visser LE, van Vliet M, van Schaik RH, Kasbergen AA, De Smet PA, Vulto AG, et al. The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Pharmacogenetics. 2004;14(1):27–33.PubMedCrossRef
311.
Visser LE, Penning-van Beest FJ, Wilson JH, Vulto AG, Kasbergen AA, De Smet PA, et al. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon. Br J Clin Pharmacol. 2004;57(4):522–4.PubMedCrossRef
312.
Visser LE, van Schaik RH, van Vliet M, Trienekens PH, De Smet PA, Vulto AG, et al. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Thromb Haemost. 2004;92(1):61–6.PubMed
313.
Visser LE, Bleumink GS, Trienekens PH, Vulto AG, Hofman A, Stricker BH. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Br J Haematol. 2004;127(1):85–9.PubMedCrossRef
314.
Visser LE, van Schaik RH, van Vliet M, Trienekens PH, De Smet PA, Vulto AG, et al. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. Clin Pharmacol Ther. 2005;77(6):479–85.PubMedCrossRef
315.
Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, et al. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism. Pharmacogenet Genomics. 2005;15(2):75–81.PubMedCrossRef
316.
Visser LE, Trienekens PH, De Smet PA, Vulto AG, Hofman A, van Duijn CM, et al. Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants. Pharmacogenet Genomics. 2005;15(2):69–74.PubMedCrossRef
317.
Schelleman H, Klungel OH, van Duijn CM, Witteman JC, Hofman A, de Boer A, et al. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy. Ann Pharmacother. 2006;40(2):212–8.PubMedCrossRef
318.
Becker ML, Visser LE, Trienekens PH, Hofman A, van Schaik RH, Stricker BH. Cytochrome P450 2C9*2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus. Clin Pharmacol Ther. 2008;83(2):288–92.PubMedCrossRef
319.
Visser LE, van Schaik RH, Jan Danser AH, Hofman A, Witteman JC, van Duijn CM, et al. The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9. Pharmacogenet Genomics. 2007;17(7):473–9.PubMedCrossRef
320.
Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, et al. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis. Br J Clin Pharmacol. 2007;64(1):57–66.PubMedCrossRef
321.
Schelleman H, Klungel OH, Witteman JC, Breteler MM, Yazdanpanah M, Danser AH, et al. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. Eur J Hum Genet. 2007;15(4):478–84.PubMedCrossRef
322.
Schelleman H, Klungel OH, Witteman JC, Breteler MM, Hofman A, van Duijn CM, et al. Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics J. 2007;7(5):346–52.PubMedCrossRef
323.
Aarnoudse AJ, Dieleman JP, Visser LE, Arp PP, van der Heiden IP, van Schaik RH, et al. Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration. Pharmacogenet Genomics. 2008;18(4):299–305.PubMedCrossRef
324.
Teichert M, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, De Smet PA, et al. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2008;28(4):771–6.PubMedCrossRef
325.
Bijl MJ, Visser LE, Hofman A, Vulto AG, van Gelder T, Stricker BH, et al. Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants. Br J Clin Pharmacol. 2008;65(4):558–64.PubMedCrossRef
326.
Becker ML, Visser LE, Newton-Cheh C, Witteman JC, Hofman A, Uitterlinden AG, et al. Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers. Diabetologia. 2008;51(11):2138–40.PubMedCrossRef
327.
Becker ML, Aarnoudse AJ, Newton-Cheh C, Hofman A, Witteman JC, Uitterlinden AG, et al. Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea. Pharmacogenet Genomics. 2008;18(7):591–7.PubMedCrossRef
328.
Bijl MJ, Visser LE, van Schaik RH, Kors JA, Witteman JC, Hofman A, et al. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users. Clin Pharmacol Ther. 2009;85(1):45–50.PubMedCrossRef
329.
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response. Pharmacogenet Genomics. 2010;20(1):38–44.PubMedCrossRef
330.
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Neurogenetics. 2011;12(1):79–82.PubMedCrossRef
331.
Teichert M, Eijgelsheim M, Uitterlinden AG, Buhre PN, Hofman A, De Smet PA, et al. Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes. Pharmacogenet Genomics. 2011;21(1):26–34.PubMedCrossRef
332.
Ruiter R, Visser LE, Eijgelsheim M, Rodenburg EM, Hofman A, Coebergh JW, et al. High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer. 2010;46(13):2467–72.PubMedCrossRef
333.
Siemes C, Visser LE, de Jong FH, Coebergh JW, Uitterlinden AG, Hofman A, et al. Cytochrome P450 3A gene variation, steroid hormone serum levels and prostate cancer—the Rotterdam Study. Steroids. 2010;75(12):1024–32.PubMedCrossRef
334.
Ruiter R, Bijl MJ, van Schaik RH, Berns EM, Hofman A, Coebergh JW, et al. CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen. Pharmacogenomics. 2010;11(10):1367–75.PubMedCrossRef
335.
Stricker BH, Stijnen T. Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies. Eur J Epidemiol. 2010;25(4):245–51.PubMedCrossRef
336.
Davis S, Mirick DK. Medication use and the risk of breast cancer. Eur J Epidemiol. 2007;22(5):319–25.PubMedCrossRef
337.
de Luise C, Lanes SF, Jacobsen J, Pedersen L, Sorensen HT. Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark. Eur J Epidemiol. 2007;22(4):267–72.PubMedCrossRef
338.
Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol. 2007;22(3):145–9.PubMedCrossRef
339.
Osterbrand M, Fahlen M, Oden A, Eliasson B. A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort. Eur J Epidemiol. 2007;22(3):151–7.PubMedCrossRef
340.
Bonovas S, Nikolopoulos G, Filioussi K, Peponi E, Bagos P, Sitaras NM. Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. Eur J Epidemiol. 2010;25(1):29–35.PubMedCrossRef
341.
Ngo AD, Taylor R, Roberts CL. Paternal exposure to Agent Orange and spina bifida: a meta-analysis. Eur J Epidemiol. 2010;25(1):37–44.PubMedCrossRef
342.
Hsia YF, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK. Eur J Epidemiol. 2009;24(4):211–6.PubMedCrossRef
343.
Ikram MA, Vrooman HA, Vernooij MW, den Heijer T, Hofman A, Niessen WJ, et al. Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging. 2010;31(3):378–86.PubMedCrossRef
344.
Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, et al. Multi-spectral brain tissue segmentation using automatically trained k-nearest-neighbor classification. Neuroimage. 2007;37(1):71–81.PubMedCrossRef
345.
van der Lijn F, den Heijer T, Breteler MM, Niessen WJ. Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts. Neuroimage. 2008;43(4):708–20.PubMedCrossRef
346.
Ikram MA, Vrooman HA, Vernooij MW, van der Lijn F, Hofman A, van der Lugt A, et al. Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol Aging. 2008;29(6):882–90.PubMedCrossRef
347.
den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, et al. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain. 2010;133(Pt 4):1163–72.CrossRef
348.
Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman A, et al. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(2):412–9.PubMedCrossRef
349.
Poels MM, Ikram MA, Vernooij MW, Krestin GP, Hofman A, Niessen WJ, et al. Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(10):1652–5.PubMedCrossRef
350.
Vernooij MW, Ikram MA, Wielopolski PA, Krestin GP, Breteler MM, van der Lugt A. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology. 2008;248(1):272–7.PubMedCrossRef
351.
Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan Study. Stroke. 2010;41(10 Suppl):S103–6.PubMedCrossRef
352.
Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–14.PubMedCrossRef
353.
Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke. 2011;42(3):656–61.PubMedCrossRef
354.
Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009;66(6):714–20.PubMedCrossRef
355.
Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL, Edinburgh Stroke Study G, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41(6):1222–8.PubMedCrossRef
356.
Vernooij MW, de Groot M, van der Lugt A, Ikram MA, Krestin GP, Hofman A, et al. White matter atrophy and lesion formation explain the loss of structural integrity of white matter in aging. Neuroimage. 2008;43(3):470–7.PubMedCrossRef
357.
de Boer R, Schaap M, van der Lijn F, Vrooman HA, de Groot M, van der Lugt A, et al. Statistical analysis of minimum cost path based structural brain connectivity. Neuroimage. 2011;55(2):557–65.PubMedCrossRef
358.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.PubMedCrossRef
359.
Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP, et al. Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam Study. Atherosclerosis. 2007;193(2):408–13.PubMedCrossRef
360.
Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP, et al. Risk factors for coronary, aortic arch and carotid calcification: the Rotterdam Study. J Hum Hypertens. 2010;24(2):86–92.PubMedCrossRef
361.
Elias-Smale SE, Odink AE, Wieberdink RG, Hofman A, Hunink MG, Krestin GP, et al. Carotid, aortic arch and coronary calcification are related to history of stroke: the Rotterdam Study. Atherosclerosis. 2010;212(2):656–60.PubMedCrossRef
362.
Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI—initial results. Stroke. 2006;37(3):818–23.PubMedCrossRef
363.
Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001;104(17):2051–6.PubMedCrossRef
364.
North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22(6):711–20.CrossRef
365.
Hofman A. New studies, technology, and the progress of epidemiology. Eur J Epidemiol. 2010;25(12):851–4.PubMedCrossRef
366.
Gondrie MJA, Mali W, Buckens CFM, Jacobs PCA, Grobbee DE, van der Graaf Y. The PROgnostic Value of unrequested Information in Diagnostic Imaging (PROVIDI) study: rationale and design. Eur J Epidemiol. 2010;25(10):751–8.PubMedCrossRef
367.
Kardys I, Deckers JW, Stricker BHC, Vletter WB, Hofman A, Witteman J. Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol. 2010;25(7):481–90.PubMedCrossRef
368.
Delaney JAC, Scherzer R, Polak J, Biggs ML, Kronmal R, Chen HY, et al. Effect of inter-reader variability on outcomes in studies using carotid intima media thickness quantified by carotid ultrasonography. Eur J Epidemiol. 2010;25(6):385–92.PubMedCrossRef
369.
Holzhauer S, Zwijsen RML, Jaddoe VWV, Boehm G, Moll HA, Mulder PG, et al. Sonographic assessment of abdominal fat distribution in infancy. Eur J Epidemiol. 2009;24(9):521–9.PubMedCrossRef
Metadata
Title
The Rotterdam Study: 2012 objectives and design update
Authors
Albert Hofman
Cornelia M. van Duijn
Oscar H. Franco
M. Arfan Ikram
Harry L. A. Janssen
Caroline C. W. Klaver
Ernst J. Kuipers
Tamar E. C. Nijsten
Bruno H. Ch. Stricker
Henning Tiemeier
André G. Uitterlinden
Meike W. Vernooij
Jacqueline C. M. Witteman
Publication date
01-08-2011
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 8/2011
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9610-5

Other articles of this Issue 8/2011

European Journal of Epidemiology 8/2011 Go to the issue

COMMENTARY

Residual confounding after adjustment for age: a minor issue in breast cancer screening effectiveness

DIABETES MELLITUS

Categories of glucose tolerance and continuous glycemic measures and mortality

Letter to the Editor

North African refugees, fleeing the fighting, admitted to Sicilian hospitals from January 1st to June 10th, 2011

MORTALITY

Determinants of 40-year all-cause mortality in the European cohorts of the Seven Countries Study

OBESITY

Obesity but not overweight is associated with increased mortality risk

CARDIOVASCULAR DISEASE

Dairy products and its association with incidence of cardiovascular disease: the Malmö diet and cancer cohort